Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)

NCT05782465 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT05782465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05782465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Active, not recruiting
Start date
August 23, 2019
Completion date
December 31, 2033
Enrollment
500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm